Status: current, Defined. Date: 31-Aug 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 627811000036114 | Candesartan/HCT 32 mg/12.5 mg (Sandoz) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 627821000036119 | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1035154223 | |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Is a | Candesartan/HCT 32 mg/12.5 mg (Sandoz) | true | Inferred relationship | Some | ||
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Is a | candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1035154222 | |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has Australian BoSS | candesartan cilexetil | true | Inferred relationship | Some | 614095173 | |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1035154222 | |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | has intended active ingredient | candesartan | true | Inferred relationship | Some | 614095173 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30 | has TPUU | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Inferred relationship | Some | 1 |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30, blister pack | has TPUU | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Inferred relationship | Some | 1 |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 500, bottle | has TPUU | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Inferred relationship | Some | 1 |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 500 | has TPUU | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Inferred relationship | Some | 1 |
| Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet, 30, bottle | has TPUU | True | Candesartan/HCT 32 mg/12.5 mg (Sandoz) tablet | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Description inactivation indicator reference set
Trade product unit of use reference set
FHIR